Case studies
Bautista, Jhommara & Villegas-Chávez, Jaime & Bunces-Larco, Doménica & Martín-Aguilera, Rafael & López-Cortés, Andrés. The microbiome as a therapeutic co-driver in melanoma immuno-oncology. Frontiers in Medicine. 2025 12.10.3389/fmed.2025.1673880.
Biagi, E., et al. Gut microbiota composition and function in extreme longevity. Current Opinion in Clinical Nutrition and Metabolic Care, 2016. 19(1), 12-17.
Galtier, M., et al. Phage therapy in the 21st century: a renewed interest in antibacterial strategies. Future Microbiology 2020, 15, 1285–1299.
HPV World. Australia on-track to be the first country to achieve cervical cancer elimination. 2025. Available at: https://www.hpvworld.com/articles/australia-on-track-to-be-the-first-country-to-achieve-cervical-cancer-elimination/
Institute for Clinical and Economic Review (ICER). Affordable Access to GLP-1 Obesity Medications: Strategies to Guide Market Action and Policy Solutions in the US. 2024.
Jia, H., & Lubetkin, E. Association of body mass index with life expectancy and active life expectancy in older adults in the Medicare Health Outcomes Survey. BMC Geriatrics 2022, 22(1), 329.
Kao, D., et al. Fecal microbiota transplantation in the management of recurrent Clostridium difficile infection. Infectious Disease Clinics of North America, 2017. 31(3), 525–541.
Kitahara, C. M., et al. Association between Class III Obesity (BMI of 40–59 kg/m2) and Mortality: A Pooled Analysis of 20 Prospective Studies. PLOS Medicine, 2014 11(7), e1001673.
National Cancer Institute. HPV and Cancer. 2023. Available at: https://www.cancer.gov/about-cancer/causes-prevention/risk/infectious-agents/hpv-fact-sheet
Nesta. Can weight loss drugs ‘solve’ obesity? Emerging weight-loss drugs hold game-changing potential as part of a prevention-focused obesity strategy. 2023. Available at: https://www.nesta.org.uk/blog/can-weight-loss-drugs-solve-obesity/
Ragonnaud, E., & Biragyn, A. The Gut Microbiota and Inflammaging: Lessons Learned from Centenarians. Trends in Immunology, 2021. 42(5), 361-364.
Routy, B., et al. Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors. Science 2018, 359(6371), 91–97.
Singer, P., & Loder, N. The $6 revolution. How generic weight loss drugs could save millions of lives. Global Health Insights. 2025. Available at: https://singerp.substack.com/p/the-6-revolution-how-generic-weight?r=1ytch0&utm_medium=ios&triedRedirect=true
Whitlock, G., et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. The Lancet, 2009 373(9669), 1083–1096.
World Economic Forum, McKinsey Health Institute. Closing the women’s health gap: a $1 trillion opportunity to improve lives and economies [Internet]. Geneva: World Economic Forum; 2024 [cited 2025 Sep 29]. Available from: https://www.mckinsey.com/mhi/our-insights/closing-the-womens-health-gap-a-1-trillion-dollar-opportunity-to-improve-lives-and-economies